Prospective validation of a biomarker-driven response prediction model to romiplostim in lower-risk myelodysplastic neoplasms - results of the EUROPE trial by EMSCO.

Autor: Kubasch AS; Department of Hematology, Cellular Therapy and Hemostaseology, Leipzig University Hospital, Leipzig, Germany.; German MDS Study Group (D-MDS), Leipzig, Germany.; The European Myelodysplastic Neoplasms Cooperative Group (EMSCO), Leipzig, Germany., Giagounidis A; German MDS Study Group (D-MDS), Leipzig, Germany.; The European Myelodysplastic Neoplasms Cooperative Group (EMSCO), Leipzig, Germany.; Department of Oncology, Hematology and Palliative Care, Marien Hospital, Düsseldorf, Germany., Metzgeroth G; Department of Hematology and Oncology, University Medical Centre, Mannheim, Germany., Jonasova A; 1st Medical Department - Hematology, General Hospital, Prague, Czech Republic., Herbst R; Medizinische Klinik III, Klinikum Chemnitz, Chemnitz, Germany., Diaz JMT; Department of Hematology and Oncology, CHU de Poitiers, Poitiers, France., De Renzis B; Service d'Hématologie Clinique Adulte, Clermont Ferrand, France., Götze KS; German MDS Study Group (D-MDS), Leipzig, Germany.; The European Myelodysplastic Neoplasms Cooperative Group (EMSCO), Leipzig, Germany.; Department of Medicine III, Technical University of Munich, Munich, Germany., Huetter-Kroenke ML; Department of Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Gourin MP; CHU Limoges, Limoges, France., Slama B; Service d'Hématologie, Centre Hospitalier d'Avignon, Avignon, France., Dimicoli-Salazar S; University Hospital Bordeaux, Pessac, France., Cony-Makhoul P; Centre Hospitalier Annecy-Genevois, Pringy, France., Laribi K; Centre Hospitalier Du Mans, Le Mans, France., Park S; Department of Hematology, CHU Grenoble, Grenoble, France., Jersemann K; GWT-TUD GmbH, Dresden, Germany., Schipp D; DS-Statistics, Rosenthal-Bielatal, Germany., Metzeler KH; Department of Hematology, Cellular Therapy and Hemostaseology, Leipzig University Hospital, Leipzig, Germany.; German MDS Study Group (D-MDS), Leipzig, Germany.; The European Myelodysplastic Neoplasms Cooperative Group (EMSCO), Leipzig, Germany., Tiebel O; Institute of Clinical Chemistry and Laboratory Medicine, Medical Faculty, Technical University Dresden, Dresden, Germany., Sockel K; German MDS Study Group (D-MDS), Leipzig, Germany.; The European Myelodysplastic Neoplasms Cooperative Group (EMSCO), Leipzig, Germany.; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany., Gloaguen S; Department of Hematology, Cellular Therapy and Hemostaseology, Leipzig University Hospital, Leipzig, Germany.; German MDS Study Group (D-MDS), Leipzig, Germany.; The European Myelodysplastic Neoplasms Cooperative Group (EMSCO), Leipzig, Germany.; GWT-TUD GmbH, Dresden, Germany., Mies A; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany., Chermat F; Groupe Francophone des Myélodysplasies, Paris, France., Thiede C; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany., Sapena R; Groupe Francophone des Myélodysplasies, Paris, France., Schlenk RF; Department of Internal Medicine V, University Hospital of Heidelberg, Heidelberg, Germany.; NCT-clinical Trials Office, German Cancer Research Center, Heidelberg, Germany., Fenaux P; The European Myelodysplastic Neoplasms Cooperative Group (EMSCO), Leipzig, Germany.; Groupe Francophone des Myélodysplasies, Paris, France.; Hématologie Clinique, Hôpital Saint-Louis, Paris, France., Platzbecker U; Department of Hematology, Cellular Therapy and Hemostaseology, Leipzig University Hospital, Leipzig, Germany. uwe.platzbecker@medizin.uni-leipzig.de.; German MDS Study Group (D-MDS), Leipzig, Germany. uwe.platzbecker@medizin.uni-leipzig.de.; The European Myelodysplastic Neoplasms Cooperative Group (EMSCO), Leipzig, Germany. uwe.platzbecker@medizin.uni-leipzig.de., Adès L; The European Myelodysplastic Neoplasms Cooperative Group (EMSCO), Leipzig, Germany.; Groupe Francophone des Myélodysplasies, Paris, France.; Hématologie Clinique, Hôpital Saint-Louis, Paris, France.

Publikováno v: Leukemia [Leukemia] 2022 Oct; Vol. 36 (10), pp. 2519-2527. Date of Electronic Publication: 2022 Sep 07.

S169: CLINICAL AND MOLECULAR MARKERS FOR PREDICTING RESPONSE TO ROMIPLOSTIM TREATMENT IN LOWER‐RISK MYELODYSPLASTIC SYNDROMES.

Autor: Kubasch, A. S., Giagounidis, A., Metzgeroth, G., Jonasova, A., Herbst, R., Diaz, J. M. T., De Renzis, B., Götze, K. S., Huetter‐Kroenke, M.‐L., Gourin, M.‐P., Slama, B., Dimicoli‐Salazar, S., Cony‐Makhoul, P., Laribi, K., Park, S., Jersemann, K., Schipp, D., Metzeler, K. H., Tiebel, O., Sockel, K.

Publikováno v: HemaSphere; 2022 Supplement 3, Vol. 6, p70-71, 2p

Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial.

Autor: Beyer-Westendorf J; Center for Vascular Medicine and Department of Medicine III, Division of Angiology, University Hospital 'Carl Gustav Carus', Technical University Dresden, Dresden, Germany; Kings Thrombosis Service, Department of Hematology, Kings College London, London, UK. Electronic address: jan.beyer@uniklinikum-dresden.de., Schellong SM; Medical Department II, Dresden Friedrichstadt Hospital, Dresden, Germany., Gerlach H; Phlebology Unit, General Medical Centre, Mannheim, Germany., Rabe E; Dermatology Department, Bonn University Hospital, Bonn, Germany., Weitz JI; McMaster University and Thrombosis and Atherosclerosis Research Institute, Hamilton, ON, Canada., Jersemann K; GWT-TUD, Dresden, Germany., Sahin K; ClinStat, Institute for Clinical Research and Statistics, Cologne, Germany., Bauersachs R; Department of Vascular Medicine, Darmstadt Municipal Hospital, Darmstadt, Germany; Centre of Thrombosis and Haemostasis, University of Mainz, Mainz, Germany.

Publikováno v: The Lancet. Haematology [Lancet Haematol] 2017 Mar; Vol. 4 (3), pp. e105-e113. Date of Electronic Publication: 2017 Feb 16.

Current evidence on the effectiveness and safety of oral anticoagulants in superficial venous thrombosis: a systematic review and meta-analysis.

Autor: DAMAY, Vito A., IVAN, Ignatius, VUYLSTEKE, Marc

Publikováno v: International Angiology; Oct2024, Vol. 43 Issue 5, p497-506, 10p

Treatment of Superficial Vein Thrombosis: Recent Advances, Unmet Needs and Future Directions.

Autor: Di Nisio, Marcello, Camporese, Giuseppe, Di Micco, Pierpaolo, Martini, Romeo, Ageno, Walter, Prandoni, Paolo

Publikováno v: Healthcare (2227-9032); Aug2024, Vol. 12 Issue 15, p1517, 9p